Human Rabies Vaccine Industry Research Report 2023
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
Highlights
The global Human Rabies Vaccine market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine.
The Human Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Rabies Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Human Rabies Vaccine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Human Rabies Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Human Rabies Vaccine segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Rabies Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Rabies Vaccine market.
Human Rabies Vaccine segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Rabies Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Rabies Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Rabies Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
Highlights
The global Human Rabies Vaccine market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine.
The Human Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Rabies Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bharat Biotech
- Bavarian Nordic
- Sanofi-Pasteur
- Chengda Bio
- KANGH
- Prcmise
- Henan Grand Biopharma
- Zhuoyi Biological
- ZhongKe Biopharm
- Ningbo Rongan Biological
- Indian Immunologicals
Global markets are presented by Human Rabies Vaccine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Human Rabies Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Human Rabies Vaccine segment by Type
- Vero Cell
- BHK
- Chick Embryo Cell
- Human Diploid Cells
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Rabies Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Rabies Vaccine market.
Human Rabies Vaccine segment by Application
- Pre-Exposure Vaccine
- Post-Exposure Vaccine
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Rabies Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Rabies Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Rabies Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Human Rabies Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Human Rabies Vaccine Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Human Rabies Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Human Rabies Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Human Rabies Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Human Rabies Vaccine Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Human Rabies Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Human Rabies Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Rabies Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Bharat Biotech Company Information
Table 17. Bharat Biotech Business Overview
Table 18. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Bharat Biotech Human Rabies Vaccine Product Portfolio
Table 20. Bharat Biotech Recent Developments
Table 21. Bavarian Nordic Company Information
Table 22. Bavarian Nordic Business Overview
Table 23. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Bavarian Nordic Human Rabies Vaccine Product Portfolio
Table 25. Bavarian Nordic Recent Developments
Table 26. Sanofi-Pasteur Company Information
Table 27. Sanofi-Pasteur Business Overview
Table 28. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Sanofi-Pasteur Human Rabies Vaccine Product Portfolio
Table 30. Sanofi-Pasteur Recent Developments
Table 31. Chengda Bio Company Information
Table 32. Chengda Bio Business Overview
Table 33. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Chengda Bio Human Rabies Vaccine Product Portfolio
Table 35. Chengda Bio Recent Developments
Table 36. KANGH Company Information
Table 37. KANGH Business Overview
Table 38. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. KANGH Human Rabies Vaccine Product Portfolio
Table 40. KANGH Recent Developments
Table 41. Prcmise Company Information
Table 42. Prcmise Business Overview
Table 43. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Prcmise Human Rabies Vaccine Product Portfolio
Table 45. Prcmise Recent Developments
Table 46. Henan Grand Biopharma Company Information
Table 47. Henan Grand Biopharma Business Overview
Table 48. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Henan Grand Biopharma Human Rabies Vaccine Product Portfolio
Table 50. Henan Grand Biopharma Recent Developments
Table 51. Zhuoyi Biological Company Information
Table 52. Zhuoyi Biological Business Overview
Table 53. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Zhuoyi Biological Human Rabies Vaccine Product Portfolio
Table 55. Zhuoyi Biological Recent Developments
Table 56. ZhongKe Biopharm Company Information
Table 57. ZhongKe Biopharm Business Overview
Table 58. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. ZhongKe Biopharm Human Rabies Vaccine Product Portfolio
Table 60. ZhongKe Biopharm Recent Developments
Table 61. Ningbo Rongan Biological Company Information
Table 62. Ningbo Rongan Biological Business Overview
Table 63. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio
Table 65. Ningbo Rongan Biological Recent Developments
Table 66. Indian Immunologicals Company Information
Table 67. Indian Immunologicals Business Overview
Table 68. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Indian Immunologicals Human Rabies Vaccine Product Portfolio
Table 70. Indian Immunologicals Recent Developments
Table 71. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 72. Global Human Rabies Vaccine Sales by Region (2018-2023) & (K Units)
Table 73. Global Human Rabies Vaccine Sales Market Share by Region (2018-2023)
Table 74. Global Human Rabies Vaccine Sales by Region (2024-2029) & (K Units)
Table 75. Global Human Rabies Vaccine Sales Market Share by Region (2024-2029)
Table 76. Global Human Rabies Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 77. Global Human Rabies Vaccine Revenue Market Share by Region (2018-2023)
Table 78. Global Human Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 79. Global Human Rabies Vaccine Revenue Market Share by Region (2024-2029)
Table 80. North America Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. North America Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 82. North America Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 83. North America Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. North America Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Europe Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Europe Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 87. Europe Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 88. Europe Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 89. Europe Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 90. Asia Pacific Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Pacific Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 92. Asia Pacific Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 93. Asia Pacific Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 94. Asia Pacific Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 95. Latin America Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Latin America Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 97. Latin America Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 99. Latin America Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 100. Middle East and Africa Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Middle East and Africa Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 103. Middle East and Africa Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Global Human Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 106. Global Human Rabies Vaccine Sales by Type (2024-2029) & (K Units)
Table 107. Global Human Rabies Vaccine Sales Market Share by Type (2018-2023)
Table 108. Global Human Rabies Vaccine Sales Market Share by Type (2024-2029)
Table 109. Global Human Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 110. Global Human Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 111. Global Human Rabies Vaccine Revenue Market Share by Type (2018-2023)
Table 112. Global Human Rabies Vaccine Revenue Market Share by Type (2024-2029)
Table 113. Global Human Rabies Vaccine Price by Type (2018-2023) & (US$/Unit)
Table 114. Global Human Rabies Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 115. Global Human Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 116. Global Human Rabies Vaccine Sales by Application (2024-2029) & (K Units)
Table 117. Global Human Rabies Vaccine Sales Market Share by Application (2018-2023)
Table 118. Global Human Rabies Vaccine Sales Market Share by Application (2024-2029)
Table 119. Global Human Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 120. Global Human Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 121. Global Human Rabies Vaccine Revenue Market Share by Application (2018-2023)
Table 122. Global Human Rabies Vaccine Revenue Market Share by Application (2024-2029)
Table 123. Global Human Rabies Vaccine Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Human Rabies Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 125. Key Raw Materials
Table 126. Raw Materials Key Suppliers
Table 127. Human Rabies Vaccine Distributors List
Table 128. Human Rabies Vaccine Customers List
Table 129. Human Rabies Vaccine Industry Trends
Table 130. Human Rabies Vaccine Industry Drivers
Table 131. Human Rabies Vaccine Industry Restraints
Table 132. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Human Rabies Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Human Rabies Vaccine Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Human Rabies Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Human Rabies Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Human Rabies Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Human Rabies Vaccine Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Human Rabies Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Human Rabies Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Rabies Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Bharat Biotech Company Information
Table 17. Bharat Biotech Business Overview
Table 18. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Bharat Biotech Human Rabies Vaccine Product Portfolio
Table 20. Bharat Biotech Recent Developments
Table 21. Bavarian Nordic Company Information
Table 22. Bavarian Nordic Business Overview
Table 23. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Bavarian Nordic Human Rabies Vaccine Product Portfolio
Table 25. Bavarian Nordic Recent Developments
Table 26. Sanofi-Pasteur Company Information
Table 27. Sanofi-Pasteur Business Overview
Table 28. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Sanofi-Pasteur Human Rabies Vaccine Product Portfolio
Table 30. Sanofi-Pasteur Recent Developments
Table 31. Chengda Bio Company Information
Table 32. Chengda Bio Business Overview
Table 33. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Chengda Bio Human Rabies Vaccine Product Portfolio
Table 35. Chengda Bio Recent Developments
Table 36. KANGH Company Information
Table 37. KANGH Business Overview
Table 38. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. KANGH Human Rabies Vaccine Product Portfolio
Table 40. KANGH Recent Developments
Table 41. Prcmise Company Information
Table 42. Prcmise Business Overview
Table 43. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Prcmise Human Rabies Vaccine Product Portfolio
Table 45. Prcmise Recent Developments
Table 46. Henan Grand Biopharma Company Information
Table 47. Henan Grand Biopharma Business Overview
Table 48. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Henan Grand Biopharma Human Rabies Vaccine Product Portfolio
Table 50. Henan Grand Biopharma Recent Developments
Table 51. Zhuoyi Biological Company Information
Table 52. Zhuoyi Biological Business Overview
Table 53. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Zhuoyi Biological Human Rabies Vaccine Product Portfolio
Table 55. Zhuoyi Biological Recent Developments
Table 56. ZhongKe Biopharm Company Information
Table 57. ZhongKe Biopharm Business Overview
Table 58. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. ZhongKe Biopharm Human Rabies Vaccine Product Portfolio
Table 60. ZhongKe Biopharm Recent Developments
Table 61. Ningbo Rongan Biological Company Information
Table 62. Ningbo Rongan Biological Business Overview
Table 63. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio
Table 65. Ningbo Rongan Biological Recent Developments
Table 66. Indian Immunologicals Company Information
Table 67. Indian Immunologicals Business Overview
Table 68. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Indian Immunologicals Human Rabies Vaccine Product Portfolio
Table 70. Indian Immunologicals Recent Developments
Table 71. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 72. Global Human Rabies Vaccine Sales by Region (2018-2023) & (K Units)
Table 73. Global Human Rabies Vaccine Sales Market Share by Region (2018-2023)
Table 74. Global Human Rabies Vaccine Sales by Region (2024-2029) & (K Units)
Table 75. Global Human Rabies Vaccine Sales Market Share by Region (2024-2029)
Table 76. Global Human Rabies Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 77. Global Human Rabies Vaccine Revenue Market Share by Region (2018-2023)
Table 78. Global Human Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 79. Global Human Rabies Vaccine Revenue Market Share by Region (2024-2029)
Table 80. North America Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. North America Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 82. North America Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 83. North America Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. North America Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Europe Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Europe Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 87. Europe Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 88. Europe Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 89. Europe Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 90. Asia Pacific Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Pacific Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 92. Asia Pacific Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 93. Asia Pacific Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 94. Asia Pacific Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 95. Latin America Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Latin America Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 97. Latin America Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 99. Latin America Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 100. Middle East and Africa Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Middle East and Africa Human Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 103. Middle East and Africa Human Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Global Human Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 106. Global Human Rabies Vaccine Sales by Type (2024-2029) & (K Units)
Table 107. Global Human Rabies Vaccine Sales Market Share by Type (2018-2023)
Table 108. Global Human Rabies Vaccine Sales Market Share by Type (2024-2029)
Table 109. Global Human Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 110. Global Human Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 111. Global Human Rabies Vaccine Revenue Market Share by Type (2018-2023)
Table 112. Global Human Rabies Vaccine Revenue Market Share by Type (2024-2029)
Table 113. Global Human Rabies Vaccine Price by Type (2018-2023) & (US$/Unit)
Table 114. Global Human Rabies Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 115. Global Human Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 116. Global Human Rabies Vaccine Sales by Application (2024-2029) & (K Units)
Table 117. Global Human Rabies Vaccine Sales Market Share by Application (2018-2023)
Table 118. Global Human Rabies Vaccine Sales Market Share by Application (2024-2029)
Table 119. Global Human Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 120. Global Human Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 121. Global Human Rabies Vaccine Revenue Market Share by Application (2018-2023)
Table 122. Global Human Rabies Vaccine Revenue Market Share by Application (2024-2029)
Table 123. Global Human Rabies Vaccine Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Human Rabies Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 125. Key Raw Materials
Table 126. Raw Materials Key Suppliers
Table 127. Human Rabies Vaccine Distributors List
Table 128. Human Rabies Vaccine Customers List
Table 129. Human Rabies Vaccine Industry Trends
Table 130. Human Rabies Vaccine Industry Drivers
Table 131. Human Rabies Vaccine Industry Restraints
Table 132. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human Rabies VaccineProduct Picture
Figure 5. Global Human Rabies Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Human Rabies Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Human Rabies Vaccine Sales (2018-2029) & (K Units)
Figure 8. Global Human Rabies Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 9. Vero Cell Product Picture
Figure 10. BHK Product Picture
Figure 11. Chick Embryo Cell Product Picture
Figure 12. Human Diploid Cells Product Picture
Figure 13. Others Product Picture
Figure 14. Pre-Exposure Vaccine Product Picture
Figure 15. Post-Exposure Vaccine Product Picture
Figure 16. Global Human Rabies Vaccine Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Human Rabies Vaccine, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Human Rabies Vaccine, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Human Rabies Vaccine Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Human Rabies Vaccine Sales by Region in 2022
Figure 23. Global Human Rabies Vaccine Revenue by Region in 2022
Figure 24. North America Human Rabies Vaccine Market Size by Country in 2022
Figure 25. North America Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 26. North America Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. United States Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Human Rabies Vaccine Market Size by Country in 2022
Figure 30. Europe Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 31. Europe Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 32. Germany Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Human Rabies Vaccine Market Size by Country in 2022
Figure 38. Asia Pacific Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 40. China Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Human Rabies Vaccine Market Size by Country in 2022
Figure 50. Latin America Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 51. Latin America Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Human Rabies Vaccine Market Size by Country in 2022
Figure 56. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Human Rabies Vaccine Sales Market Share by Type (2018-2029)
Figure 62. Global Human Rabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 63. Global Human Rabies Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 64. Global Human Rabies Vaccine Sales Market Share by Application (2018-2029)
Figure 65. Global Human Rabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 66. Global Human Rabies Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 67. Human Rabies Vaccine Value Chain
Figure 68. Human Rabies Vaccine Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Human Rabies Vaccine Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human Rabies VaccineProduct Picture
Figure 5. Global Human Rabies Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Human Rabies Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Human Rabies Vaccine Sales (2018-2029) & (K Units)
Figure 8. Global Human Rabies Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 9. Vero Cell Product Picture
Figure 10. BHK Product Picture
Figure 11. Chick Embryo Cell Product Picture
Figure 12. Human Diploid Cells Product Picture
Figure 13. Others Product Picture
Figure 14. Pre-Exposure Vaccine Product Picture
Figure 15. Post-Exposure Vaccine Product Picture
Figure 16. Global Human Rabies Vaccine Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Human Rabies Vaccine, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Human Rabies Vaccine, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Human Rabies Vaccine Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Human Rabies Vaccine Sales by Region in 2022
Figure 23. Global Human Rabies Vaccine Revenue by Region in 2022
Figure 24. North America Human Rabies Vaccine Market Size by Country in 2022
Figure 25. North America Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 26. North America Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. United States Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Human Rabies Vaccine Market Size by Country in 2022
Figure 30. Europe Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 31. Europe Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 32. Germany Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Human Rabies Vaccine Market Size by Country in 2022
Figure 38. Asia Pacific Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 40. China Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Human Rabies Vaccine Market Size by Country in 2022
Figure 50. Latin America Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 51. Latin America Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Human Rabies Vaccine Market Size by Country in 2022
Figure 56. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Human Rabies Vaccine Sales Market Share by Type (2018-2029)
Figure 62. Global Human Rabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 63. Global Human Rabies Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 64. Global Human Rabies Vaccine Sales Market Share by Application (2018-2029)
Figure 65. Global Human Rabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 66. Global Human Rabies Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 67. Human Rabies Vaccine Value Chain
Figure 68. Human Rabies Vaccine Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Human Rabies Vaccine Industry Opportunities and Challenges
